- Genetics news | Genetics news news are updated once a hour
- We deliver news from more than 500 sources on genetics
NewsAdvertisers: |
Firm to produce new bird flu vaccine for poultry (genetics news)... will start to produce the vaccine up to a million doses per month. Also in the near future, IPB Shigeta will start to build a new factory with capacity of 100 million doses per month for chickens," Nishio said.The company is a joint venture between Bogor Agricultural University (IPB) and Japan's Shigeta Animal Pharmaceuticals. Its plant is located near the university's campus in Bogor south of Jakarta.Reverse Scientists find key cichlid gene (genetics news)... One of the genes identified, called microfibril-associated glycoprotein 4 (magp4), is known to cause a disease called Smith-Magenis Syndrome (SMS) in humans. Smith-Magenis Syndrome causes facial defects, and further studies on the cichlids showed that the magp4 gene was being expressed in the jaws of cichlid fry, and that different species such as Paralabidochromis (Haplochromis) chilotes and Paralabidochromis (Haplochromis) sp. "Rock Kribensis" differed in the way the gene worked. They believe the gene might be the one responsible for the diversification of the cichlid jaw that has led to the adaptive radiation of these fish. Previous scientists have said that the jaw and pharyngeal area of cichlids represents a key evolutionary innovation. The jaw and pharyngeal area is one of the most important anatomical features in cichlid systematics. For more information see: Kobayashi N, Watanabe M, Kijimoto T, Fujimura K, Nakazawa M, Ikeo K, Kohara Y, Gojobori T, Okada N (In press) - magp4 gene may contribute to the diversification of cichlid morphs and their speciation. Gene, 20... Targeted Genetics Reports Fourth Quarter and Year-End 2005 ... (genetics news)... Revenue for the fourth quarter ended December 31, 2005 was $1.9 million, compared to $3.2 million for the fourth quarter of 2004. Revenue for the year ended December 31, 2005 was $6.9 million, compared to $9.7 million for the year ended December 31, 2004. Revenue in 2005 was primarily due to manufacturing and development under the HIV/AIDS vaccine collaboration with IAVI and to a lesser degree, collaborations with Celladon Corporation and Sirna Therapeutics. Revenue in 2004 was primarily due to manufacturing and development revenues earned under our collaboration with IAVI. These forth quarter and fiscal 2005 results are preliminary and subject to change pending the completion of the fiscal 2005 audit by the Company's independent registered public accounting firm. Accordingly, the announced results may differ from what the Company eventually files in its Annual Report on Form 10-K for the fiscal year ended December 31, 2005. The Company expects to complete the audit and file the Form 10-K by March 14, 2006. "In 2005, we intensified our focus on the clinical advanc... genetics news page 1 | genetics news page 2 | genetics news page 3 | genetics news page 4 | genetics news page 5 | genetics news page 6 | genetics news page 7 | genetics news page 8 | genetics news page 9 | genetics news page 10 | genetics news page 11 | genetics news page 12 | genetics news page 13 | genetics news page 14 | genetics news page 15 | genetics news page 16 | genetics news page 17 | genetics news page 18 | genetics news page 19 | genetics news page 20 | genetics news page 21 | genetics news page 22 | genetics news page 23 | genetics news page 24 | genetics news page 25 | genetics news page 26 | genetics news page 27 | genetics news page 28 | genetics news page 29 | genetics news page 30 | genetics news page 31 | genetics news page 32 | genetics news page 33 | genetics news page 34 | genetics news page 35 | genetics news page 36 | genetics news page 37 | genetics news page 38 | genetics news page 39 | genetics news page 40 | genetics news page 41 | genetics news page 42 | genetics news page 43 | genetics news page 44 | genetics news page 45 | genetics news page 46 | genetics news page 47 | genetics news page 48 | genetics news page 49 | genetics news page 50 | genetics news page 51 | genetics news page 52 | genetics news page 53 | genetics news page 54 | genetics news page 55 | genetics news page 56 | genetics news page 57 | genetics news page 58 | genetics news page 59 | genetics news page 60 | genetics news page 61 | genetics news page 62 | genetics news page 63 | genetics news page 64 | genetics news page 65 | genetics news page 66 | genetics news page 67 | genetics news page 68 | genetics news page 69 | genetics news page 70 | genetics news page 71 | genetics news page 72 | genetics news page 73 | genetics news page 74 | genetics news page 75 | genetics news page 76 | genetics news page 77 | genetics news page 78 | genetics news page 79 | genetics news page 80 | genetics news page 81 | genetics news page 82 | genetics news page 83 | genetics news page 84 | genetics news page 85 | genetics news page 86 | genetics news page 87 | genetics news page 88 | genetics news page 89 | genetics news page 90 | genetics news page 91 | genetics news page 92 | genetics news page 93 | genetics news page 94 | genetics news page 95 | genetics news page 96 | genetics news page 97 | genetics news page 98 | genetics news page 99 | All genetics news Alcohol Abuse, Allergy, Anxiety, Arthritis, Bipolar Disorder, Breast Cancer, Depression, Diabetes, Erectile Dysfunction, Sexual Dysfunction, Women orgasm, Kidney Cancer, Liver Cancer, Lung Cancer, Menopause, Melanoma, Oral Cancer, Prostate Cancer, Sexual health, United states news, New York daily, Space industry
 >
|